🔗 Visit the ClinicalTrials.gov page for NCT01586195
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | The MAPK pathway across different malignancies: a new perspective. | Cancer | 2014 | 1.22 |
| 2 | Dabrafenib and its potential for the treatment of metastatic melanoma. | Drug Des Devel Ther | 2012 | 1.16 |
| 3 | Vemurafenib: a new treatment for BRAF-V600 mutated advanced melanoma. | Cancer Manag Res | 2012 | 0.91 |
| 4 | Advances in personalized targeted treatment of metastatic melanoma and non-invasive tumor monitoring. | Front Oncol | 2013 | 0.89 |